Assessing Inequalities In Health & Quality Of Life

Published Apr 17, 2013
Wirral, UK - How should we monitor health disparities across districts? Traditionally, governments measure economic outputs such as gross domestic product (GDP) and health outcomes such as life expectancy. Life expectancy only tells part of the picture; when we adjust life expectancy for health status, the gaps between rich and poor often become even wider. In the study, “Using a Survey to Estimate Health Expectancy and Quality-Adjusted Life Expectancy to Assess Inequalities in Health and Quality of Life,” published in Value in Health, author Brendan Collins, of the University of Liverpool and Wirral Public health, combined health-related quality of life data from a population questionnaire with life expectancy data to estimate quality adjusted life expectancy across a population. This study showed that the gap between rich and poor was much greater when quality of life was included as well as life expectancy. The study revealed a 12.7 year gap in quality adjusted life expectancy between rich and poor in Wirral, an area in the North West of England. The potential value of this gap in quality adjusted life years (QALYs) can be valued in economic terms based on society’s willingness to pay for health interventions. Fiona Johnstone, Wirral’s Director of Policy, Performance & Public Health said, “Combining life expectancy data with quality of life data in this way enables us to understand more about the needs of our population and how individuals in our most deprived areas do not just have shorter life expectancy, but are more likely to experience poor health at every age.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

From Promise to Proof: Strengthening the Evidence Base for Digital Health Technologies

Apr 28, 2026

Value in Health announced the publication of a special themed section of research papers that advances evidence and methods for evaluating the real-world value of digital health technologies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×